Font Size: a A A

Expression And Significance Of Tumor Stem Cell Related Markers CD44+/CD24-/Low And ALDH1+ In Triple Negative Breast Cancer Tissues

Posted on:2019-05-30Degree:MasterType:Thesis
Country:ChinaCandidate:A A WangFull Text:PDF
GTID:2334330542964827Subject:Pathology and pathophysiology
Abstract/Summary:PDF Full Text Request
Objective:Investigating the expression of aldehyde dehydrogenases 1?ALDH1?and CD44+/CD24-/low in triple negative breast cancer?TNBC?tissues and its relationship with prognosis of triple negative breast cancerMethods:Immunohistochemistry was used to detect the express of ALDH1 and CD44+/CD24-/low in formalin-fixed paraffin-embedded?FFPE?tissue samples of triple negative breast cancer.Student t test and Pearson's chi-square was used to analyze the expression of aldehyde dehydrogenases L?ALDH1?and CD44+/CD24-/low/low in triple negative breast cancer?TNBC?tissues and its relationship with prognosis of triple negative breast cancer.Results:The expression rate of ALDH1+in TNBC tissues was?14?46.67%,and the expression rates of CD44+/CD24-/low were?17?56.67%.The expression rate of ALDH1+,and the positive rate of CD44+/CD24-/low expression in non-triple negative breast cancer tissues was?5?16.67%,and?8?26.67%,respectively.The positive expression rates of ALDH1 and CD44+/CD24-/low in TNBC tissues were significantly higher than those in non-triple negative breast tissues.The local recurrence and distant metastasis rates of patients with CD44+/CD24-/low and ALDH1?+?group were significantly higher than those of other three negative breast cancer patients.Conclusions:Overexpression of ALDH1+and CD44+/CD24-/low in TNBC tissues is an independent risk factor for prognosis in TNBC patients,and is involved in the regulation of TNBC occurrence and prognosis.
Keywords/Search Tags:Triple Negative Breast Cancer, ALDH1, CD44+/CD24-/low phenotype cell, Prognosis
PDF Full Text Request
Related items